The Dickinson Group employs synthetic organic chemistry, molecular evolution, and protein design to develop molecular technologies to study and control chemistry in living systems. The group's current primary research interests include: 1) developing new evolution technologies to reprogram and control biomolecular interactions, 2) engineering RNA-targeting biotechnologies as new therapeutic platforms, and 3) developing novel proximity-labeling chemistries to study biomolecular interactions. The motivating principle of the Dickinson Group is that our ability as chemists to create functional molecules through both rational and evolutionary approaches will lead to new breakthroughs in biology and biotechnology.